Study #2012-0441
Prospective Assessment of Correlative and Tissue Biomarkers in Glioma Patients (The PROACTIVE-Glioma Program) - A Biomarker-Driven Program for Clinical Trial Development for Newly Diagnosed and Recurrent Glioma Patients
MD Anderson Study Status
Enrolling
Treatment Agent
Description
PROACTIVE-Glioma Program
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Vinaykumar Puduvalli
Department:
Neuro-Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.